VolitionRX Ltd
VNRX0.628USD
-0.012-1.91%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
63.25MCap. mercado
PérdidaP/E TTM
Más Datos de VolitionRX Ltd Compañía
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Información de la empresa
Símbolo de cotizaciónVNRX
Nombre de la empresaVolitionRX Ltd
Fecha de salida a bolsaFeb 06, 2015
Director ejecutivoDr. Jasmine Kway
Número de empleados85
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 06
Dirección1489 West Warm Springs Road
CiudadHENDERSON
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal89014
Teléfono17024251561
Sitio Webhttps://volition.com/
Símbolo de cotizaciónVNRX
Fecha de salida a bolsaFeb 06, 2015
Director ejecutivoDr. Jasmine Kway
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.81M
+0.72%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.08M
+10.62%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
456.18K
-4.51%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
362.01K
+38.17%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
313.51K
-1.40%
Dr. Alan Colman, Ph.D.
Dr. Alan Colman, Ph.D.
Independent Director
Independent Director
203.55K
-10.28%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
191.11K
+4.56%
Mr. Gael Forterre
Mr. Gael Forterre
Chief Commercial Officer
Chief Commercial Officer
159.47K
+0.29%
Mr. Nicholas Plummer
Mr. Nicholas Plummer
Group General Counsel
Group General Counsel
144.80K
-3.61%
Mr. Rodney Gerard Rootsaert
Mr. Rodney Gerard Rootsaert
Corporate Secretary
Corporate Secretary
138.29K
-2.17%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.81M
+0.72%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.08M
+10.62%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
456.18K
-4.51%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
362.01K
+38.17%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
313.51K
-1.40%
Dr. Alan Colman, Ph.D.
Dr. Alan Colman, Ph.D.
Independent Director
Independent Director
203.55K
-10.28%
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 5 de jul
Actualizado: sáb., 5 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Cotterford Co., Ltd.
11.65%
Lagoda Investment Management, L.P.
9.89%
Armistice Capital LLC
7.97%
Innes (Guy Archibald)
2.72%
Reynolds (Cameron John)
2.02%
Other
65.74%
Accionistas
Accionistas
Proporción
Cotterford Co., Ltd.
11.65%
Lagoda Investment Management, L.P.
9.89%
Armistice Capital LLC
7.97%
Innes (Guy Archibald)
2.72%
Reynolds (Cameron John)
2.02%
Other
65.74%
Tipos de accionistas
Accionistas
Proporción
Corporation
12.63%
Investment Advisor
11.32%
Hedge Fund
8.01%
Individual Investor
7.32%
Investment Advisor/Hedge Fund
1.09%
Research Firm
0.04%
Venture Capital
0.03%
Other
59.56%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
78
41.39M
40.17%
+893.35K
2025Q1
83
44.42M
46.85%
+2.70M
2024Q4
82
41.53M
44.82%
+1.50M
2024Q3
82
38.59M
41.90%
+9.42M
2024Q2
82
28.77M
32.86%
+105.49K
2024Q1
84
28.22M
34.52%
+1.47M
2023Q4
87
26.17M
37.10%
+183.39K
2023Q3
91
25.37M
36.48%
-477.38K
2023Q2
98
25.03M
37.36%
-1.92M
2023Q1
127
25.94M
45.68%
-639.07K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Cotterford Co., Ltd.
12.01M
11.65%
--
--
Apr 25, 2025
Lagoda Investment Management, L.P.
10.19M
9.89%
+2.62M
+34.56%
Mar 31, 2025
Armistice Capital LLC
8.21M
7.97%
-275.46K
-3.25%
Mar 31, 2025
Innes (Guy Archibald)
2.81M
2.72%
+20.00K
+0.72%
Jun 03, 2025
Reynolds (Cameron John)
1.88M
1.83%
+12.50K
+0.67%
Jun 12, 2025
Concord International Inc.
1.01M
0.98%
--
--
Apr 25, 2025
Geode Capital Management, L.L.C.
761.95K
0.74%
+18.11K
+2.43%
Mar 31, 2025
The Vanguard Group, Inc.
706.06K
0.69%
+69.39K
+10.90%
Mar 31, 2025
Micallef (Jacob Vincent)
456.18K
0.44%
-21.53K
-4.51%
Jun 01, 2025
BlackRock Institutional Trust Company, N.A.
445.19K
0.43%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
